Pre-listing trading for JIANGXI BIO (06915), which is scheduled to list on the Hong Kong exchange on Tuesday, June 30th, has commenced.

As of the latest update, the indicative price in the pre-market session is HK$10. This represents a decline of 10.71% from its initial public offering price of HK$11.2 per share.

Based on a board lot size of 500 shares and excluding transaction fees, this price movement translates to a loss of HK$600 per board lot.